Skip to content

Psychodynamic group therapy for people with schizophrenic psychosis during covid-19-pandemic

Psychodynamic group therapy for people with schizophrenic psychosis during covid-19-pandemic

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00033756
Enrollment
7
Registered
2024-03-20
Start date
2022-08-11
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F20

Interventions

Group 1: qualitative study: Routine data in the form of tape recordings of group psychotherapy sessions were analyzed retrospectively. And data like age, gender and diagnosis.

Sponsors

Charité
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with a schizophrenic disorder without an addiction requiring prior treatment

Exclusion criteria

Exclusion criteria: primary addiction requiring treatment

Design outcomes

Primary

MeasureTime frame
Topics discussed in a psychodynamic group psychotherapy of schizophrenic patients during the outbreak of the Covid-19 pandemic, mapped in the category system by qualitative content analysis according to Mayring. (qualitative Study)

Secondary

MeasureTime frame
Consistency of the topics discussed in the group psychotherapy of schizophrenic patients with the psychodynamic psychosis theory of Stavros Mentzos

Countries

Germany

Contacts

Public ContactDorothea von Haebler

Charité

dorothea.vonhaebler@ipu-berlin.de+493045050

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026